Results from a tricor weight-loss study are encouraging.

Published Date: 18 Oct 2023

Participants in the SURMOUNT-3 study who were given a random assignment to take tirzepatide for 72 weeks experienced a total mean reduction in baseline body weight after losing weight for the first 12 weeks through an intensive lifestyle intervention alone.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot